Neural Inhibition of Dopaminergic Signaling Enhances Immunity in a Cell-Non-autonomous Manner

Current Biology

Volumn 26, Issue 17, 2016, Pages 2329-2334

  Cao, Xiou ^a   Aballay, Alejandro ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAENORHABDITIS ELEGANS PROTEIN; CHLORPROMAZINE; DOP-4 PROTEIN, C ELEGANS; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL; CAENORHABDITIS ELEGANS; GENETICS; INNATE IMMUNITY; METABOLISM; NERVE CELL; NERVE CELL INHIBITION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CHLORPROMAZINE; DOPAMINE; DOPAMINE ANTAGONISTS; IMMUNITY, INNATE; NEURAL INHIBITION; NEURONS; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 84981736928     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2016.06.036     Document Type: Article

References (22)

1. 1 Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124 (2006), 783–801.
2. 2 Cho, J.H., Feldman, M., Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat. Med. 21 (2015), 730–738.
3. 3 Sternberg, E.M., Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6 (2006), 318–328.
4. 4 Aballay, A., Role of the nervous system in the control of proteostasis during innate immune activation: insights from C. elegans. PLoS Pathog., 9, 2013, e1003433.
5. 5 Veiga-Fernandes, H., Mucida, D., Neuro-immune interactions at barrier surfaces. Cell 165 (2016), 801–811.
6. 6 Andersson, U., Tracey, K.J., Neural reflexes in inflammation and immunity. J. Exp. Med. 209 (2012), 1057–1068.
7. 7 Tracey, K.J., Reflex control of immunity. Nat. Rev. Immunol. 9 (2009), 418–428.
8. 8 Pavlov, V.A., Tracey, K.J., The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat. Rev. Endocrinol. 8 (2012), 743–754.
9. 9 Chavan, S.S., Tracey, K.J., Regulating innate immunity with dopamine and electroacupuncture. Nat. Med. 20 (2014), 239–241.
10. 10 Torres-Rosas, R., Yehia, G., Peña, G., Mishra, P., del Rocio Thompson-Bonilla, M., Moreno-Eutimio, M.A., Arriaga-Pizano, L.A., Isibasi, A., Ulloa, L., Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat. Med. 20 (2014), 291–295.
11. 11 Lotharius, J., Brundin, P., Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3 (2002), 932–942.
12. 12 Wise, R.A., Dopamine, learning and motivation. Nat. Rev. Neurosci. 5 (2004), 483–494.
13. 13 Beaulieu, J.-M., Gainetdinov, R.R., The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63 (2011), 182–217.
14. 14 Levite, M., Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol. (Oxf.) 216 (2016), 42–89.
15. 15 Pacheco, R., Prado, C.E., Barrientos, M.J., Bernales, S., Role of dopamine in the physiology of T-cells and dendritic cells. J. Neuroimmunol. 216 (2009), 8–19.
16. 16 Cai, Y., Cao, X., Aballay, A., Whole-animal chemical screen identifies colistin as a new immunomodulator that targets conserved pathways. MBio, 5, 2014 e01235-14.
17. 17 Styer, K.L., Singh, V., Macosko, E., Steele, S.E., Bargmann, C.I., Aballay, A., Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR. Science 322 (2008), 460–464.
18. 18 Meisel, J.D., Kim, D.H., Behavioral avoidance of pathogenic bacteria by Caenorhabditis elegans. Trends Immunol. 35 (2014), 465–470.
19. 19 Bolz, D.D., Tenor, J.L., Aballay, A., A conserved PMK-1/p38 MAPK is required in Caenorhabditis elegans tissue-specific immune response to Yersinia pestis infection. J. Biol. Chem. 285 (2010), 10832–10840.
20. 20 Inoue, H., Hisamoto, N., An, J.H., Oliveira, R.P., Nishida, E., Blackwell, T.K., Matsumoto, K., The C. elegans p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response. Genes Dev. 19 (2005), 2278–2283.
21. 21 van der Hoeven, R., McCallum, K.C., Cruz, M.R., Garsin, D.A., Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity via p38 MAPK signaling during infection in C. elegans. PLoS Pathog., 7, 2011, e1002453.
22. 22 Sugiura, M., Fuke, S., Suo, S., Sasagawa, N., Van Tol, H.H.M., Ishiura, S., Characterization of a novel D2-like dopamine receptor with a truncated splice variant and a D1-like dopamine receptor unique to invertebrates from Caenorhabditis elegans. J. Neurochem. 94 (2005), 1146–1157.